Rinko Ghosh

60 year

Consumer Services

Health Technology

Profile

Rinko Ghosh worked as the Chief Business Officer & Senior Vice President at Nektar Therapeutics from 2010 to 2014, and as the President & Chief Business Officer at Symic Bio, Inc. from 2016 to 2018.
Ghosh holds an MBA from the University of Pennsylvania, a graduate degree from Vanderbilt University, and an undergraduate degree from the Indian Institute of Technology Bombay.

Former positions of Rinko Ghosh

Companies	Position	End
Symic Bio, Inc. Symic Bio, Inc. BiotechnologyHealth Technology Symic Bio, Inc. develops new category of therapeutics. The company studies treatments for osteoarthritis and cardiovascular ailments. The firm developed a new therapeutic category of bioconjugates that directly target the extracellular matrix, the biologically active environment which plays critical roles for cell proliferation, migration, differentiation and survival. The company was founded by Kate Stuart and John Paderi in 2012 and is headquartered in San Francisco, CA.	President	2017-12-31
NEKTAR THERAPEUTICS	Corporate Officer/Principal	2014-03-14

See the detail of Rinko Ghosh's experience

Training of Rinko Ghosh

University of Pennsylvania	Masters Business Admin
Indian Institute of Technology Bombay	Undergraduate Degree
Vanderbilt University	Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Rinko Ghosh's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
NEKTAR THERAPEUTICS	Health Technology

Private companies	1
Symic Bio, Inc. Symic Bio, Inc. BiotechnologyHealth Technology Symic Bio, Inc. develops new category of therapeutics. The company studies treatments for osteoarthritis and cardiovascular ailments. The firm developed a new therapeutic category of bioconjugates that directly target the extracellular matrix, the biologically active environment which plays critical roles for cell proliferation, migration, differentiation and survival. The company was founded by Kate Stuart and John Paderi in 2012 and is headquartered in San Francisco, CA.	Health Technology